- Report
- February 2024
- 126 Pages
Global
From €2686EUR$2,990USD£2,311GBP
- Report
- February 2024
- 122 Pages
Global
From €2686EUR$2,990USD£2,311GBP
- Report
- September 2022
- 232 Pages
Global
From €3144EUR$3,500USD£2,705GBP
- Report
- April 2022
- 326 Pages
Global
From €3368EUR$3,750USD£2,899GBP
- Report
- September 2022
- 120 Pages
North America
From €3099EUR$3,450USD£2,667GBP
- Report
- September 2022
- 136 Pages
Europe
From €3099EUR$3,450USD£2,667GBP
- Report
- August 2021
- 163 Pages
Global
From €3997EUR$4,450USD£3,440GBP
- Report
- May 2025
- 318 Pages
Global
From €4033EUR$4,490USD£3,470GBP
- Report
- May 2025
- 320 Pages
Global
From €4033EUR$4,490USD£3,470GBP
- Report
- April 2025
- 175 Pages
Global
From €4033EUR$4,490USD£3,470GBP
- Report
- December 2024
- 175 Pages
Global
From €4491EUR$5,000USD£3,865GBP
- Report
- December 2024
- 175 Pages
Global
From €3593EUR$4,000USD£3,092GBP
- Report
- December 2024
- 175 Pages
Global
From €4491EUR$5,000USD£3,865GBP
- Report
- February 2024
- 175 Pages
Global
From €4491EUR$5,000USD£3,865GBP
- Report
- January 2024
- 200 Pages
Global
From €4491EUR$5,000USD£3,865GBP
- Report
- January 2023
- 470 Pages
Global
From €4491EUR$5,000USD£3,865GBP
- Report
- September 2025
- 70 Pages
India
From €3144EUR$3,500USD£2,705GBP
- Report
- September 2025
- 82 Pages
Japan
From €3144EUR$3,500USD£2,705GBP
- Report
- May 2025
- 86 Pages
United States
From €3144EUR$3,500USD£2,705GBP
- Report
- May 2025
- 185 Pages
Global
From €4042EUR$4,500USD£3,478GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more